Corporate governance > Leadership team
According to the Articles of Incorporation, Revenio Group Corporation shall have a President and CEO. The CEO’s task is to manage the operation of the Company in accordance with guidelines and rules laid out by the Board of Directors, and inform the Board of the development of the Company’s business operations and financial position. Additionally, the CEO is responsible for organizing the Company’s day-to-day management and to ensure that the Company’s asset management is arranged in a reliable way. The CEO is appointed by the Board of Directors, which also specifies the terms and conditions of the CEO’s employment in a written employment contract that has been approved by the Board of Directors. The contract also contains the financial benefits of the employment, such as severance pay and any other compensations. The CEO may not be elected as Chair of the Board of Directors.
Revenio Group's Leadership Team consists of the President & CEO, heads of various functions, and Managing Directors of the Group's subsidiaries.
In contrast to the Company’s statutory governing bodies, the duties of the Leadership Team are operational. The Leadership Team convenes at least once a month.
planning and monitoring investments;
preparing for and implementing corporate acquisitions;
preparing strategy proposals;
managing and monitoring daily business operations;
measures related to preparatory work for Board meetings.
Kate has been Director of Oculo since 2015. Previously Kate has worked in strategy, policy and advocacy with McKinsey & Company, the World Economic Forum's Global Health Initiative, International AIDS Vaccine Initiative, and GlaxoSmithKline Biologicals. She was appointed a member of Revenio Group's Leadership Team from May 28, 2021.
Heli has been QA Manager of Icare Finland Oy since 2010. Previously Heli has worked as QA Manager at Plexpress Oy, as CTO at CTT Cancer Targeting Technologies Ltd and as Research Scientist at University of Helsinki, Haartman Institute. She was appointed a member of Revenio Group's Leadership Team from February 1, 2018.
Ari has been Operations Director of Icare Finland Oy since 2012. Previously Ari has worked in executive positions in production, purchasing and logistics in companies operating in national and international markets, such as Perlos and Ensto. He was appointed a member of Revenio Group's Leadership Team from June 1, 2016.
Tomi has been Sales & Marketing Director of Icare Finland Oy since 2015. Previously Tomi worked in various managerial positions in international business and sales and marketing in the field of health technology such as Datex-Ohmeda, Spacelabs, Perlos and Medisize. Tomi has worked as Hospital Division Director at Serres Oy and he was one of the forerunners who introduced the Medical IT business to Germany and Austria. He was appointed a member of Revenio Group's Leadership Team starting from August 6, 2015.
Robin has been CFO of Revenio Group Corporation since 2015. Previously Robin has worked in several managerial positions in international corporations both in Finland and Canada. He has solid experience in various financial management roles. He was appointed a member of Revenio Group's Leadership Team since August 6, 2015.
Hanna has been Director, People & Culture of Revenio Group Corporation since August 2021. Previously Hanna has worked in strategic and operative HR in international organizations, such as Director, HR Business Partner at Varian Medical Systems and HR development and management tasks at Telia, BearingPoint and Murata. She was appointed a member of Revenio Group's Leadership Team from August 16, 2021.
John has been the President and CEO of Icare USA Inc. since 2010. Previously John has worked as a Regional Sales Manager at Synemed, as a Sales Representative at Nidek Medical and as an owner at Visionary Medical Solutions. He was appointed a member of Revenio Group’s Leadership Team from February 1, 2023.
Marco Rizzardo has more than 20 years of experience in research and development of advanced medical technologies such as surgical robotics and digital solutions in leading roles of global companies. He has most recently worked as Technical Director in Alifax Srl, Italy and before that as Head of Medical Software in Cambridge Consultants Ltd, Great Britain.
Rizzardo will start in his position no later than January 8, 2024.